SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 75 filers reported holding SESEN BIO INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,004,113 | +30.9% | 1,646,442 | -7.9% | 0.00% | – |
Q3 2022 | $767,000 | -27.4% | 1,787,320 | +37.1% | 0.00% | – |
Q2 2022 | $1,056,000 | +51.1% | 1,303,895 | +12.0% | 0.00% | – |
Q1 2022 | $699,000 | -79.3% | 1,163,751 | -71.7% | 0.00% | – |
Q4 2021 | $3,372,000 | +124.1% | 4,117,906 | +117.1% | 0.00% | – |
Q3 2021 | $1,505,000 | -81.3% | 1,897,072 | +8.8% | 0.00% | -100.0% |
Q2 2021 | $8,058,000 | +55.0% | 1,744,252 | -12.8% | 0.00% | – |
Q1 2021 | $5,199,000 | +440.4% | 1,999,638 | +180.4% | 0.00% | – |
Q4 2020 | $962,000 | +945.7% | 713,018 | +978.7% | 0.00% | – |
Q3 2020 | $92,000 | +29.6% | 66,100 | -32.6% | 0.00% | – |
Q2 2020 | $71,000 | -85.9% | 98,057 | -89.1% | 0.00% | – |
Q1 2020 | $503,000 | -39.6% | 896,839 | +12.1% | 0.00% | – |
Q4 2019 | $833,000 | +73.5% | 800,149 | +94.9% | 0.00% | – |
Q3 2019 | $480,000 | -26.2% | 410,582 | -5.3% | 0.00% | – |
Q2 2019 | $650,000 | +1447.6% | 433,777 | +976.1% | 0.00% | – |
Q1 2019 | $42,000 | -95.9% | 40,309 | -91.5% | 0.00% | – |
Q3 2018 | $1,018,000 | +37.9% | 473,680 | +25.0% | 0.00% | – |
Q2 2018 | $738,000 | – | 378,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |